Our research expertise spans cancer genomics, DNA damage, RNA biology, and drug development. We are also expanding our focus on drug delivery, particularly through nanotechnology-based methods for delivering small RNA mimics and inhibitors.
News
- Zhao Lai, PhD to Receive $365K NIH Grant to Expand Integrated High-Performance Imaging-Based in-situ Spatial Profiling
- Molecular Cancer Therapeutics: Targeting DDR2 for Treating Pancreatic Cancer (Rao Lab & Chen)
- BioRxiv: Robust statistical assessment of Oncogenotype to Organotropism translation in xenografted zebrafish (Kurmasheva, et al)
- Daohong Zhou, MD, to Receive $2.4M CPRIT Award to Better Identify Therapeutic Targets and Develop Technologies to Target Hard-to-Treat Cancers.
- Advanced Science: Biosecurity Primitive: Polymerase X-based Genetic Physical Unclonable Functions (Pertsemlidis)
Events
Greehey CCRI Seminar Series – Fall ’25: Yatin M. Vyas, MBBS (Penn State Health)
Presentation Title: TBD
Greehey CCRI Seminar Series – Fall ’25: Manjeet Rao, PhD (UTHSA)
Presentation title: Disrupting Astrocyte–Tumor Crosstalk to Target Metabolic Vulnerabilities in Medulloblastoma
4th Annual Gear Up Against Kids Cancer Bike Ride
We’re excited to announce that the 4th Annual Gear Up Against Kids Cancer has been rescheduled for Saturday, October 18, 2025, at a new location: Floresville City Park (756 TX-97, Floresville, TX 78114), right next to the Event Center.